Drug Shortage Report for DALACIN T 1%
Report ID | 14425 |
Drug Identification Number | 00582301 |
Brand name | DALACIN T 1% |
Common or Proper name | Dalacin T |
Company Name | PFIZER CANADA ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | CLINDAMYCIN |
Strength(s) | 1% |
Dosage form(s) | SOLUTION |
Route of administration | TOPICAL |
Packaging size | 60mL |
ATC code | D10AF |
ATC description | ANTI-ACNE PREPARATIONS FOR TOPICAL USE |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2018-01-26 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2019-03-11 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-06-29 | English | Compare |
v2 | 2017-06-29 | French | Compare |
v3 | 2017-09-20 | English | Compare |
v4 | 2017-12-14 | English | Compare |
v5 | 2017-12-14 | French | Compare |
v6 | 2018-01-30 | English | Compare |
v7 | 2018-01-30 | French | Compare |
v8 | 2019-03-11 | English | Compare |
v9 | 2019-03-11 | French | Compare |
Showing 1 to 9 of 9